Joshua Lehrer-Graiwer - 23 Apr 2026 Form 3 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Reporting relationship: Director
Issuer ticker: FULC
Reported as of: 23 Apr 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 01 May 2026, 16:10:03 UTC
Prior SEC filing: 23 Feb 2023
Next SEC filing: 28 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Alan Musso as attorney-in-fact for Joshua Lehrer-Graiwer

Filing notes and source

Key filing fact

Joshua Lehrer-Graiwer filed Form 3 for Fulcrum Therapeutics, Inc. (FULC) on 01 May 2026.

Key facts

This page summarizes Joshua Lehrer-Graiwer's Form 3 filing for Fulcrum Therapeutics, Inc. (FULC).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 01 May 2026, 16:10.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

CIK 0001789673 Primary reporting owner

Shares, units, or other non-derivative securities reported in this filing.

FULC holding

No transaction description listed

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

SEC remarks

Exhibit Index: 24.1 Power of Attorney